21 CFR Part 528 — Intentional Genomic Alterations in Animals

PART 528—INTENTIONAL GENOMIC ALTERATIONS IN ANIMALS Authority: 21 U.S.C. 360b. Source: 74 FR 6823, Feb. 11, 2009, unless otherwise noted. § 528.1080 Bc2371 recombinant deoxyribonucleic acid construct. (a) Specifications and intended use. Oryctolagus cuniculus (b) Sponsor. (c) Conditions of use Intended use. (2) Limitations. [84 FR 12494, Apr. 2, 2019] § 528.1092 opAFP-GHc2 recombinant deoxyribonucleic acid construct. (a) Specifications. opAFP-GHc2 Salmo salar (b) Sponsor. (c) Indications for use. (d) Limitations. [80 FR 73104, Nov. 24, 2015] § 528.2000 Deletion of exon 7 of CD163 gene in domestic pigs. (a) Specifications. CD163 Sus scrofa domesticus (b) Sponsor. (c) Conditions of use Intended use. CD163 Sus scrofa domesticus) D E7 [90 FR 40970, Aug. 22, 2025] § 528.2001 pPL657 (a) Specifications. pPL657 glycoprotein galactosyltransferase alpha-1,3 GGTA1 (b) Sponsor. (c) Conditions of use Intended use. pPL657 glycoprotein galactosyltransferase alpha-1,3 GGTA1 Sus scrofa domesticus (2) Limitations. pPL657 [86 FR 17064, Apr. 1, 2021] § 528.2010 Human lysosomal acid lipase recombinant deoxyribonucleic acid construct. (a) Specifications. Gallus gallus (b) Sponsor. (c) Conditions of use Intended use. (2) Limitations. [81 FR 17608, Mar. 30, 2016]

Related documents

• 50 CFR Part 635 — Atlantic Highly Migratory Species#512150
• 21 CFR Part 514 — New Animal Drug Applications#506850
• Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN#908732
• 21 CFR Part 501 — Animal Food Labeling#506844
• 7 CFR Part 1465 — Agricultural Management Assistance#504590